Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLOSE-3
2022-000624-37Phase 3Active
- Sponsor
- Laboratorios Salvat, S.A.
- Start
- May 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in Postoperative ocular inflammation and post-operative ocular pain comparing Clobetasol propionate ophthalmic nanoemulsion arm with Prednisolone acetate ophthalmic suspension arm (2 arms). Primary endpoint: Percentage of patients with anterior chamber inflammation of grade 0. Started May 2022; status: active.
02
Drugs
clobetasolprednisolone
03
Conditions
Postoperative ocular inflammationpost-operative ocular pain
Beyond the preview
Go deeper on 2022-000624-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000624-37.